Finance

Lists
Why is AUPH up 4,13%?
Dive Deeper
AUPH:NASDAQ
Aurinia Pharmaceuticals Inc
16,89 $
+4,13%
(+0,67) 1D
9 հոկ, 14:55:30 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUPH...
Open
16,16 $
High
16,97 $
Low
16,12 $
Mkt. cap
2,25 մլրդ
Avg. vol.
806,16 հզր
Volume
477,22 հզր
P/E ratio
7,38
52-wk high
19,25 $
52-wk low
10,92 $
EPS
2,29 $
Beta
1,60
Shares outstanding
133,05 մլն
No. of employees
128
Open
16,16 $
High
16,97 $
Low
16,12 $
Mkt. cap
2,25 մլրդ
Avg. vol.
806,16 հզր
Volume
477,22 հզր
P/E ratio
7,38
52-wk high
19,25 $
52-wk low
10,92 $
EPS
2,29 $
Beta
1,60
Shares outstanding
133,05 մլն
No. of employees
128
News stories
From web sources and news partners
About Aurinia Pharmaceuticals Inc
CEO-
Employees128
Founded2012
HeadquartersԷդմոնտոն, Ալբերտա, Կանադա
Sector-
Websiteauriniapharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to AUPH in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AUPH in the last 3 months.
Highest
Current 16,89 $
21,00 $ (+24,33%)
Average
18,00 $ (+6,57%)
Lowest
16,00 $ (-5,27%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Martin PhD
Bloom Burton
Buy
Upgraded
21,00 $
+24,3%
08/20/2026
Stacy Ku
TD Cowen
Buy
Maintained
17,00 $
+0,7%
08/19/2026
Douglas Miehm
RBC Capital
Hold
Maintained
16,00 $
-5,3%
08/07/2026
Arthur He CFA
H.C. Wainwright
Buy
Reiterated
17,00 $
+0,7%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
73,47 մլն
77,11 մլն
77,70 մլն
83,22 մլն
Cost of goods sold
8,50 մլն
40,55 մլն
13,98 մլն
18,30 մլն
Cost of revenue
8,50 մլն
40,55 մլն
13,98 մլն
18,30 մլն
Research and development expenses
8,11 մլն
-20,86 մլն
-
1,31 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,18 մլն
29,26 մլն
22,03 մլն
23,51 մլն
Operating expense
35,22 մլն
-6,37 մլն
22,31 մլն
18,58 մլն
Total operating expenses
43,72 մլն
34,18 մլն
36,28 մլն
36,88 մլն
Operating income
29,74 մլն
42,94 մլն
41,42 մլն
46,34 մլն
Other non operating income
-
-
-
-
EBT including unusual items
31,96 մլն
35,69 մլն
43,92 մլն
48,79 մլն
EBT excluding unusual items
31,96 մլն
35,69 մլն
43,92 մլն
48,79 մլն
Income tax expense
411,00 հզր
-175,10 մլն
9,57 մլն
11,37 մլն
Effective tax rate
1,29%
-490,62%
21,79%
23,31%
Other operating expenses
929,00 հզր
-14,77 մլն
279,00 հզր
-6,23 մլն
Net income
31,55 մլն
210,79 մլն
34,36 մլն
37,41 մլն
Net profit margin
42,95%
273,35%
44,21%
44,96%
Earnings per share
0,23
1,53
0,25
0,28
Interest and investment income
3,32 մլն
3,50 մլն
3,52 մլն
3,39 մլն
Interest expense
-1,10 մլն
-1,05 մլն
-1,01 մլն
-948,00 հզր
Net interest expenses
2,22 մլն
2,45 մլն
2,50 մլն
2,44 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
34,61 մլն
47,80 մլն
46,24 մլն
51,18 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps